Log in

OWPC One World Products, Inc. OTC · United States

One World Products (OWPC) news

One World Products, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker OWPC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest One World Products news

We have not published a story on One World Products yet. When there is news, it will appear here.

One World Products annual financials

LineFY2024FY2023
Revenue$4,863$7,589
Net income (loss)-$3.9 million-$4.0 million
Cash from operations-$1.1 million-$1.2 million

Latest balance sheet, Dec 31, 2022 (10-K): cash and equivalents $11,016.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about One World Products

What is the ticker symbol of One World Products?

One World Products, Inc. trades under the ticker OWPC on OTC.

Where is One World Products listed?

One World Products, Inc. is listed on OTC.

Which country or territory is One World Products listed under?

Our directory records One World Products, Inc. under United States.

Does aibio.space cover One World Products?

aibio.space lists One World Products, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

What was One World Products's revenue last year?

$4,863 for the fiscal year ended Dec 31, 2024, as reported to the SEC.

Is One World Products profitable?

One World Products, Inc. reported a net loss of $3.9 million for the fiscal year ended Dec 31, 2024, and used $1.1 million of cash in operations, per its annual report to the SEC.

How much cash does One World Products have?

$11,016 in cash at Dec 31, 2022, per its 10-K.

Investor discussion: One World Products

Members talk about One World Products (OWPC). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:OWPC on TradingView.

Listing details

One World Products, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker OWPC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
One World Products, Inc.
Ticker
OWPC
Listing
OTC
Country or territory
United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.